Indication Landscape (Non-generic products): Marketed & R&D (PI to Filed)

 
 
ProductProduct
Generic NameGeneric Name
CompanyCompany
WW Indication LaunchWW Indication Launch US Indication LaunchUS Indication Launch USA Indication Status (Current) Europe Indication LaunchEurope Indication Launch Europe Indication Status (Current) Japan Indication LaunchJapan Indication Launch Japan Indication Status (Current) China Indication Status (Current) RoW Indication Status (Current)
General biliary disorders                        
  Marketed Cholbam cholic acid Asklepion Pharmaceuticals 02/04/2015 04/08/2015 Marketed 02/04/2015 Withdrawn - - - Phase III
  Cholbam cholic acid Retrophin 02/04/2015 04/08/2015 Marketed 02/04/2015 Marketed - - - Phase III
  Orphacol cholic acid Laboratoires C.T.R.S. 04/07/2013 - - 04/07/2013 Marketed - - - -
  Compound Dantong Capsules herbal extract Tianyin Pharmaceutical 30/06/2010 - - - - - - Marketed -
  Pankreaplex Mono curcuma xanthorizza extract Schaper & Brümmer - - - - - - - - Marketed